ライフサイエンスコーパス: HFE

1 HFE 187C>G and, possibly, mitochondrial haplogroup J gav

2 HFE 187C/G heterozygotes (n = 23) had less limb fat loss

3 HFE and Nramp2 (DMT1) genes are reciprocally regulated.

4 HFE and transferrin receptor 2 (TFR2) are each necessary

5 HFE and transferrin receptor 2 (TFR2) are membrane prote

6 HFE C282Y homozygosity had the most marked independent a

7 HFE gene testing can be used to diagnose hemochromatosis

8 HFE genetic variations did not correlate with outcomes,

9 HFE interacts with the BMP6-SMAD signaling pathway to re

10 HFE is expressed in retinal pigment epithelium (RPE), an

11 HFE is not involved in regulation of BMP6 by iron, but d

12 HFE is the principal regulator of iron homeostasis, and

13 HFE mutations are associated with impaired hepatic bone

14 HFE mutations have traditionally been associated with th

15 HFE(-/-) livers were overloaded with ferritin but had lo

16 HFE, a major regulator of iron (Fe) homeostasis, has bee

17 HFE-associated hemochromatosis is characterized by abnor

18 of BMP/Smad-related genes was examined in 20 HFE-HH males with significant iron overload, and compare

19 HAMP and HJV in 96 patients with PCT and 88 HFE C282Y homozygotes with marked hepatic iron overload.

20 g highly fluorinated electrolytes based on a HFE solvent.

21 Identifying the adaptive HFE variants in Asians will not only elucidate the evolu

22 In addition, HFE potentially modulates cellular iron uptake by intera

23 n stores and serum hepcidin level across all HFE genotypes.

24 in levels than subjects without iron for all HFE genotypes (P < 0.0001).

25 Although HFE mutations (especially the most frequent H63D mutatio

26 study was to examine the relationships among HFE genotype, serum hepcidin level, hepatic iron deposit

27 hemochromatosis, which is often caused by an HFE mutation, may have retinal iron overload predisposin

28 elded in subjects with at least 1 copy of an HFE variant compared with wild-type subjects.

29 American ethnicity (OR: 1.8; P = 0.001) and HFE C282Y heterozygosity (OR: 1.9; P = 0.003) were assoc

30 rican ethnicity (OR </=0.9; P </= 0.049) and HFE C282Y (OR </=0.84; P </= 0.060) were independently a

31 We used the AGS and MKN1 gastric cancer and HFE-145 immortalized non-neoplastic gastric mucosa cell

32 s) in the COMT, NTRK1, BDNF, ErbB4, CLU, and HFE genes, and investigated their individual and aggrega

33 candidate SNPs (COMT, NTRK1, ErbB4, CLU, and HFE) explained approximately 6% of the variance in the a

34 tive age and are influenced by ethnicity and HFE C282Y.

35 ered by LPS, indicating that ferroportin and HFE protein down-regulation alone are insufficient to ma

36 causing poorer surface expression of HFE and HFE:TFR1 complex (nonfunctional TFR1) in peritoneal macr

37 or age, sex, ethnicity, body mass index, and HFE genotype status.

38 m was to assess the relationship of iron and HFE genetic variations to progression and outcomes in th

39 and transferrin saturation measurements and HFE genotyping.

40 Ectopic CagA expression in AGS, MKN1 and HFE-145 cells showed a significant increase in HER-2 gen

41 imethyl ether, ammonia, R-152a, propane, and HFE-152a all performed effectively in a 1 ton window uni

42 s a cross-sectional study of iron status and HFE mutations in primary care patients at 5 centers in t

43 s associated with transferrin levels, TF and HFE, and found that a commonly carried polymorphism (H63

44 gments physically disparate from the TfR and HFE binding sites.

45 TfR2-TfR1 and HFE-HLA-B7 chimeras were generated to map the domains of

46 eir similar overall structures with TfR2 and HFE, respectively.

47 coproteins transferrin receptor 2 (TfR2) and HFE are associated with hereditary hemochromatosis.

48 beta-Thalassemia and HFE-related hemochromatosis are 2 of the most frequently

49 Interactions between HFE and transferrin receptor 1 (TfR1) have been mapped t

50 ls were fit to evaluate interactions between HFE genotype and particulate matter < or = 2.5 microm in

51 tudy was to examine the relationship between HFE mutations and histological severity in a large North

52 s studies examining the relationship between HFE mutations and severity of nonalcoholic steatohepatit

53 R2 lower hepcidin levels, implying that both HFE and TfR2 are necessary for regulation of hepcidin ex

54 pathway to regulate hepcidin expression, but HFE is not necessary for hepcidin induction by BMP6.

55 in, but it is hindered little, if at all, by HFE.

56 es were estimated from age 40 to 75 years by HFE genotype and sex.

57 In Caucasians, C282Y HFE homozygotes are numerous, but they are only predispo

58 spite increased iron level in cells carrying HFE H63D, it appeared that ER stress was not responsive

59 ssible, and testing for the common causative HFE mutations is now widely available in clinical labora

60 As in HepG2 cells, HFE expression inhibited NTBI uptake by approximately 50

61 We characterized HFE polymorphisms 845G>A and 187C>G and European mitocho

62 carrying the mouse equivalent of the common HFE C282Y human disease-causing mutation (murine C294Y)

63 opean ancestry at the 6p22 region containing HFE and LRRC16A was associated with higher Hgb.

64 anemia (ferritin < 10 ng/mL), iron-depleted HFE hemochromatosis, and juvenile hemochromatosis.

65 ng the relative solvating power of different HFEs with distinct structural features, and considering

66 ene most often mutated in the human disease, HFE, has been deleted (Hfe(/)).

67 Mutations in either HFE or TfR2 lower hepcidin levels, implying that both HF

68 omponent was observed in persons with either HFE variant.

69 factor displayed by electrolytes that employ HFE cosolvents, we have established the quantitative str

70 hromatosis include defects in genes encoding HFE, transferrin receptor 2, ferroportin, hepcidin, and

71 the risk of recurring heart failure events (HFEs) was a pre-specified substudy of MADIT-CRT (Multice

72 fically during brief, high-frequency events (HFEs) in the local field potential that are similar to r

73 life of Zip14 is lower in cells that express HFE.

74 ed ER stress, the number of cells expressing HFE H63D in early apoptosis was increased moderately.

75 in another cell line, HeLa cells expressing HFE under the tetracycline-repressible promoter were tra

76 alpha-helices of the histone fold extension (HFE) of the Cenp-T histone fold domain (HFD) combining w

77 TfR2, HJV, BMP6, and, to a lesser extent, HFE are required for the hepcidin response to acute iron

78 chment eyes, RDE) and 5 healthy fellow eyes (HFE) of 5 patients (mean age 59.8 years, macula-off dura

79 ent eyes, RDE) and five healthy fellow-eyes (HFE) of five patients (mean age 59.8 years, macula-off d

80 s and their hydrolysates from fenugreek (FE, HFE) and quinoa (QE, HQE), and saponin and sapogenin sta

81 significant reduction in the risk of a first HFE (hazard ratio [HR]: 0.54, 95% confidence interval [C

82 iduals homozygous for the variant coding for HFE p.Cys282Tyr and 397 compound heterozygotes with vari

83 vel of the majority of adult homozygotes for HFE mutations does not rise over long periods of time, e

84 plasmic domain of HFE might be necessary for HFE-mediated induction of hepcidin.

85 confirmed all seven cases were negative for HFE mutations C282Y and H63D.

86 This review considered genetic screening for HFE-related hereditary hemochromatosis in C282Y homozygo

87 my constitutes the established treatment for HFE-related hemochromatosis.

88 y treatment for potential complications from HFE-related hereditary hemochromatosis (HH).

89 Hearts from HFE(-/-) mice with hemochromatosis contained slightly mo

90 282Y heterozygotes have been identified from HFE gene sequencing.

91 1, ATP2B1, SH2B3/ATXN2, CSK, CYP17A1, FURIN, HFE, LSP1, MTHFR, SOX6) at array-wide significance (P <

92 r that mimics a human haemochromatosis gene (HFE) mutation.

93 ndrial haplogroups and hemochromatosis gene (HFE) polymorphisms have been associated with ART-induced

94 in the hereditary hemochromatosis (hh) gene (HFE) explain the siderosis in approximately 20% patients

95 2 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6

96 ci, some including known iron-related genes (HFE, SLC40A1, TF, TFR2, TFRC, TMPRSS6) and others novel

97 de significance, and 6 (FIGN, ULK4, GUCY1A3, HFE, TBX3-TBX5, and TBX3) at a suggestive level of P = 1

98 he prevalence of heterozygous C282Y and H63D HFE mutations was 14.3% and 21.4%, respectively, in the

99 biopsy and genotyping for the C282Y and H63D HFE mutations were performed in all subjects.

100 regulatory protein activity than WT or H63D HFE.

101 HFE-mutant mice that recapitulates the H63D-HFE mutation in humans.

102 pigenetic regulation in the brain using H67D HFE-mutant mice that recapitulates the H63D-HFE mutation

103 Similar to halothane, HFE had no measurable effects on the gA channel structur

104 e TfR1 cofactor hereditary hematochromatosis HFE protein.

105 While mutation in the hemochromatosis ( HFE) gene disrupts iron homeostasis and promotes oxidati

106 Genotyping for hemochromatosis (HFE) gene status was performed.

107 ed in two genetic models of hemochromatosis (HFE-null mouse and HJV-null mouse) and in two nongenetic

108 nteracts with its receptor, hemochromatosis (HFE) protein, to modulate iron responsive pathways in ca

109 ts at the transferrin (TF), hemochromatosis (HFE), fatty acid desaturase 2 (FADS2)/myelin regulatory

110 cipants that tested for the hemochromatosis (HFE) C282Y genotype and iron status.We sought to determi

111 The protein product of the hemochromatosis (HFE) gene modulates uptake of iron and divalent cations

112 pecific polymorphism in the hemochromatosis (HFE) gene, H63D, is over-represented in neurodegenerativ

113 m (H63D at rs1799945) in the hemochromatotic HFE gene was associated with white matter fiber integrit

114 osis-associated proteins: HJV (hemojuvelin), HFE (hemochromatosis protein), and TfR2 (transferrin rec

115 emochromatosis-related proteins hemojuvelin, HFE and transferrin receptor 2, also regulates hepcidin

116 Hemojuvelin (HJV), HFE, and transferrin receptor-2 (TfR2) facilitate this p

117 s the other BMPs in association with the HJV/HFE/TfR2 complex; they provide an explanation for the co

118 one regulator of systemic iron homeostasis, HFE, is expressed in the RPE.

119 naling has not been characterized in a human HFE-HH cohort to date.

120 echocystis sp. PCC 6803 rbcL gene, and human HFE.

121 In this work, we report a hydrofluoroether (HFE) solvent-based electrolyte for electrochemical proce

122 Hydrofluoroethers (HFEs) have been adopted widely as electrolyte cosolvents

123 In contrast, hydrofluoroethers (HFEs) have high oxidative stability but do not dissolve

124 ent emissions for several hydrofluoroethers (HFEs) and other potential replacements were compared to

125 To determine if HFE had a similar effect on Zip14 in another cell line,

126 ure episodes after a first post-implantation HFE.

127 In HFE, mean cone density retrieved from IS/OS & COST remai

128 In HFE, mean cone density retrieved from IS/OS and COST rem

129 y of all measured locations remained 18dB in HFE and was significantly lower in RDE with 14.30dB at B

130 er of insulin resistance, and iron burden in HFE hemochromatosis.

131 1) and gene variants linked to cirrhosis (in HFE and SERPINA1).

132 e or more recessive traits, most commonly in HFE and SERPINA1 genes.

133 of all measured locations remained 18 dB in HFE and was significantly lower in RDE, with 14.30 dB at

134 ession of BMP6 was appropriately elevated in HFE-HH compared to controls (P = 0.02), likely related t

135 e associated with elevated serum ferritin in HFE C282Y homozygotes.

136 mapped to the alpha1- and alpha2-helices in HFE and to the helical domain of TfR1.

137 t ARNTL, TF, and TFR2 affect iron markers in HFE C282Y homozygotes at risk for hemochromatosis.

138 ho were homozygous for the C282Y mutation in HFE and had undergone a liver biopsy with quantification

139 However, we found that the same mutation in HFE does not affect the TfR2/HFE interaction.

140 Mutations in HFE are responsible for approximately 90% of cases of th

141 Mutations in HFE are the most common cause of the iron-overload disor

142 Mutations in HFE cause the most common form of hereditary hemochromat

143 Mutations in HFE lead to hereditary hemochromatosis (HH) because of i

144 In hereditary hemochromatosis, mutations in HFE lead to iron overload through abnormally low levels

145 Mutations in HFE, HJV, and TfR2 cause autosomal-recessive forms of he

146 Mutations in HFE, transferrin receptor 2 (Tfr2), hemojuvelin (HJV), o

147 on overload arising mostly from mutations in HFE.

148 esting that impaired BMP signaling occurs in HFE-HH.

149 es have confirmed that disease penetrance in HFE-related hereditary hemochromatosis is lower than pre

150 is associated with a high-iron phenotype in HFE C282Y homozygotes and may participate in hepcidin re

151 itors of BMP signaling, were up-regulated in HFE-HH compared to controls (P = 0.001 and P = 0.018, re

152 ith variability of iron overload severity in HFE-associated hemochromatosis, we performed exome seque

153 ntial for normal iron homeostasis, including HFE, transferrin receptor 2 (TfR2), and hemojuvelin, fun

154 lp hepcidin to monitor serum iron, including HFE and, in rarer instances, transferrin-receptor 2 and

155 ellular iron content [anti-import: TFRC(Low)/HFE(High); or pro-export: SLC40A1 (ferroportin)(High)/HA

156 s in the heart, despite the absence of major HFE gene mutations.

157 rformed exome sequencing of DNA from 35 male HFE C282Y homozygotes with either markedly increased iro

158 nt iron overload, and compared to seven male HFE wild-type controls using quantitative real-time reve

159 ygous mutant or compound heterozygous mutant HFE genotypes.

160 that express either wild-type (WT) or mutant HFE to determine the cellular consequences of the mutant

161 sly associated with these traits (HBS1L-MYB, HFE, TMPRSS6, TFR2, SPTA1) as well as new associations (

162 5]; P = .046) compared with men with neither HFE variant.

163 D genotypes compared with those with neither HFE variants.

164 opathological papers on several forms of non-HFE hemochromatosis were published and Wilson's disease

165 required to identify patients with rare, non-HFE forms of the disease.

166 < 8.56 x 10(-7) at four further loci (NPR3, HFE, NOS3, and SOX6).

167 s and cardiac failure despite the absence of HFE mutations.

168 Our results indicate parallel adaptation of HFE gene in Europeans and Asians with different genetic

169 further interrogate the structural basis of HFE function in the pathophysiology of HH.

170 It is shown that the characteristics of HFE hemochromatosis can be reproduced by increasing the

171 gnaling underlies the hepcidin deficiency of HFE-HH.

172 esized that the small, cytoplasmic domain of HFE might be necessary for HFE-mediated induction of hep

173 dues 104 and 250 and to the alpha3 domain of HFE, both of which differ from the TfR1/HFE interacting

174 of Zip14 with siRNA abolished the effect of HFE on NTBI uptake.

175 iculum, causing poorer surface expression of HFE and HFE:TFR1 complex (nonfunctional TFR1) in periton

176 In the present study, the expression of HFE and the HFE-interacting proteins TfR1, TfR2, and bet

177 Expression of HFE decreased both TBI and NTBI uptake.

178 Expression of HFE has not been investigated in the retina.

179 Expression of HFE in intact retina was investigated by in situ hybridi

180 his is the first report on the expression of HFE in the retina.

181 RT-PCR was used to detect the expression of HFE mRNA in neural retina and the RPE-eyecup.

182 RT-PCR showed predominant expression of HFE mRNA in the RPE-eyecup.

183 Expression of HFE-interacting proteins was also analyzed using similar

184 ndations on returning incidental findings of HFE variants in individuals undergoing genome-scale sequ

185 beta2M is essential for proper folding of HFE, CD1, and MHC class I and their surface expression.

186 both TfR1 and TfR2 binding, a mutant form of HFE (W81AHFE) that has an approximately 5,000-fold lower

187 cellular consequences of the mutant forms of HFE.

188 f our study was to investigate the impact of HFE on GABAergic neurochemistry and redox-epigenetic reg

189 of this work was to assess the influence of HFE mutations and serum and hepatic measures of iron sta

190 The specific localization of HFE and its interacting proteins, TfR1 and TfR2, at the

191 abrogated by disease-associated mutations of HFE and TFR2, and that TFR2 competes with TFR1 for bindi

192 Mutations of HFE are best known as being associated with cellular iro

193 regulation is central to the pathogenesis of HFE hemochromatosis.

194 Because the penetrance of HFE hemochromatosis is low, traditional population scree

195 involved as a modulator of the penetrance of HFE hemochromatosis since fat mass is associated with ov

196 RSS6 might modify the clinical penetrance of HFE-associated hereditary hemochromatosis, raising the p

197 Presence of HFE mutations, in particular the H63D variation, was ass

198 ncommon disorder, although the prevalence of HFE (High Iron) 282 Cys --> Tyr (C282Y) homozygosity is

199 significant differences in the prevalence of HFE gene mutations among subjects with fibrosis (35.5%)

200 The rate of HFE c.845G>A (p.Cys282Tyr) homozygotes in the CRC group

201 PCT was significantly reduced, regardless of HFE genotype, when compared with patients with hh but wi

202 hepcidin regulation in NAFLD, regardless of HFE genotype.

203 atments resulted in rapid down-regulation of HFE protein [encoded by the hemochromatosis gene (Hfe)]

204 ther, our results suggest a putative role of HFE in regulating labile iron status in the brain, and m

205 In this study, we investigated the role of HFE in the regulation of both transferrin-bound iron (TB

206 However, the role of HFE in this process was never explored.

207 beta2M interaction leads to sequestration of HFE in endoplasmic reticulum, causing poorer surface exp

208 dominantly in hepatocytes, the major site of HFE expression in the liver.

209 The occurrence of HFEs greatly increased the risk of death.

210 of place-specific neural activity outside of HFEs.

211 imilar magnitude of reduction in the risk of HFEs subsequent to a first post-enrollment event (HR: 0.

212 ytes that combine the oxidative stability of HFEs with the ionic conductivity of ethers in a single c

213 chemically orthogonal electrolytes based on HFE solvents do not dissolve organic perovskite films an

214 rmed the signatures of positive selection on HFE in Asian populations and identified a candidate adap

215 Moreover, natural selection on HFE may have contributed to elevated Fe absorption in As

216 Thirty-five percent carried at least one HFE gene mutation.

217 Inhibition of either beta2-M or HFE results in reversion of EMT.

218 ecessive disorder associated with pathogenic HFE variants, most commonly those resulting in p.Cys282T

219 The hereditary hemochromatosis protein HFE promotes the expression of hepcidin, a circulating h

220 Finally, the protein HFE associates with the transferrin receptor and is part

221 Defects in human hemochromatosis protein (HFE) cause iron overload due to reduced hepatic hepcidin

222 Mutations in hemochromatosis protein (HFE) or transferrin receptor 2 (TFR2) cause hereditary h

223 s in the hereditary hemochromatosis protein (HFE), transferrin-receptor 2 (TfR2), hemojuvelin, hepcid

224 nctional hereditary hemochromatosis protein, HFE, causes iron overload predominantly in hepatocytes,

225 s of the hereditary hemochromatosis proteins HFE and transferrin receptor 2 may intersect with the BM

226 ation therapy for the reduction in recurring HFEs was maintained after the occurrence of a first post

227 Data with regard to recurring HFEs were prospectively collected for all 1,820 MADIT-CR

228 A significantly reduced HFE expression was observed in individuals carrying T/T

229 The homeostatic iron regulator (HFE) also regulates hepcidin through a mechanism that in

230 g for C282Y (rs1800562) and H63D (rs1799945) HFE mutations was performed in 786 adult subjects in the

231 The occurrences of first and second HFEs were associated with 7- and nearly 19-fold respecti

232 To test whether similar HFE residues are important for both TfR1 and TfR2 bindin

233 ion was performed in the fluorinated solvent HFE-7100.

234 D for the prevention of first and subsequent HFEs was pronounced among patients with left bundle bran

235 only risk for nonfatal first- and subsequent-HFEs was assessed by Cox proportional hazards and Anders

236 when it comes to selecting the most suitable HFE electrolyte cosolvent for different battery systems.

237 with beta2M causes downregulation of surface HFE, a protein regulating iron homeostasis via interacti

238 finding indicates that the TfR2/HFE and TfR1/HFE interactions are distinct.

239 n of HFE, both of which differ from the TfR1/HFE interacting domains.

240 We further observed that, unlike TfR1/HFE, Tf does not compete with HFE for binding to TfR2 an

241 This finding indicates that the TfR2/HFE and TfR1/HFE interactions are distinct.

242 ame mutation in HFE does not affect the TfR2/HFE interaction.

243 ere generated to map the domains of the TfR2/HFE interaction.

244 tely 5,000-fold lower affinity for TfR1 than HFE was employed.

245 ole to hepcidin regulation by iron, and that HFE regulates hepcidin at least in part through a BMP2-i

246 Here we demonstrate that HFE and TFR2 interact in cells, that this interaction is

247 Furthermore, we found that HFE increases TfR2 levels in hepatic cells independent o

248 We hypothesize that HFE modulates erythropoiesis by affecting dietary iron a

249 patients with HFE mutations, indicating that HFE regulates hepcidin.

250 hybridization in intact retina revealed that HFE mRNA is expressed almost exclusively in RPE Immunofl

251 d immunogold electron microscopy showed that HFE protein was specifically associated with the basolat

252 These results suggest that HFE decreases the stability of Zip14 and therefore reduc

253 The HFE C282Y heterozygous mutation is associated with advan

254 present study, the expression of HFE and the HFE-interacting proteins TfR1, TfR2, and beta2M were ana

255 mochromatosis is predominantly caused by the HFE p.C282Y homozygous pathogenic variant.

256 Patients with HH carrying the HFE gene who were homozygous for the Cys282Tyr mutation,

257 Studies on heterozygotes for the HFE mutation were excluded.

258 onstrate that the different mutations in the HFE gene have unique effects on the cells and provide in

259 Mutations in the HFE gene may influence development or progression of chr

260 verload disorder results from defects in the HFE gene product, a major histocompatibility complex cla

261 mozygous for the p.Cys282Tyr mutation in the HFE gene underwent LT between 1999 and 2008.

262 ar that the two most common mutations in the HFE gene, H63D and C282Y, may be genetic modifiers for r

263 ide polymorphism (SNP) discrimination in the HFE gene, responsible for hereditary hemochromatosis.

264 he disease and results from mutations in the HFE gene.

265 The C282Y mutation in the HFE hemochromatosis gene occurs more commonly in autoimm

266 n, has been associated with mutations in the HFE, transferrin receptor-2 (TfR2), and hemojuvelin (HJV

267 The discovery of the HFE gene in 1996 heralded a decade of major advances in

268 carry the missense Cys282Tyr mutation of the HFE gene.

269 osis is that caused by C282Y mutation of the HFE gene.

270 H-SY5Y, we reported that the presence of the HFE H63D protein activated the unfolded protein response

271 thway may be defective in the absence of the HFE protein.

272 s for future study about the function of the HFE protein.

273 Expression of the HFE-interacting proteins TfR1, TfR2, and beta2M was also

274 Overall, our studies indicate that the HFE H63D mutant protein is associated with prolonged ER

275 e and the electrochemical performance of the HFEs.

276 ansferrin concentrations transmitted through HFE, TfR2, and HJV augment BMP receptor sensitivity to B

277 total of 1051 out of 1145 subjects agreed to HFE mutational testing (C282Y, H63D, S65C).

278 that TFR2 competes with TFR1 for binding to HFE.

279 t IS/OS and COST was still lower compared to HFE and ranged between 7 790 and 9 555 cones/mm(2) (p<.0

280 t IS/OS and COST was still lower compared to HFE and ranged between 7790 and 9555 cones/mm(2) (P < .0

281 In comparison to HFE, RDE showed highly irregular cone patterns in AO-OCT

282 In comparison to HFE, RDE showed highly irregular cone patterns in AO-OCT

283 1,2,2-tetrafuoroethyl-2',2',2'-trifuoroethyl(HFE) are introduced into the high-concentration sulfolan

284 Two HFE polymorphisms (C282Y and H63D) associated with incre

285 Uncommon HFE mutations resulting in phenotypic hemochromatosis am

286 roles of BMP2 compared with BMP6 and whether HFE regulates hepcidin through a BMP2-dependent mechanis

287 To more definitively determine whether HFE regulates hepcidin expression through an interaction

288 We investigated whether HFE is involved in BMP6-SMAD regulation of hepcidin expr

289 odegeneration, it is largely unknown whether HFE mutation modifies GABAergic homeostasis and emotiona

290 ar iron overload, but the mechanism by which HFE H63D might increase the risk of neuron degeneration

291 and sustained virologic responses (20% with HFE mutation vs 14% sustained virologic response without

292 verlap with metabolites that associated with HFE or SERPINA1 variants.

293 t, unlike TfR1/HFE, Tf does not compete with HFE for binding to TfR2 and that binding is independent

294 nd for roles in host homeostasis (e.g., with HFE and ZAG).

295 tly, TfR2 was also reported to interact with HFE in transfected mammalian cells.

296 Among men with HFE p.C282Y homozygosity, there was a significantly incr

297 mochromatosis mouse models and patients with HFE mutations, indicating that HFE regulates hepcidin.

298 Men and women with HFE p.C282Y and p.H63D genotypes compared with those wit

299 y component between persons with and without HFE variants was significant (P for interaction=0.02).

300 vs 14% sustained virologic response without HFE mutation; P = .009).